Seed, Pre-Seed
$250K – $2.0M
$50M
7+ companies
1 partner
Investment Thesis
Targets AI-driven automation solutions disrupting health and life sciences, as well as adjacent enterprise tools.
Meet the Team
Industry Focus
Invests In
Portfolio Companies (7)
Other
PathScan AI
WorkCycle
Vittoria Biotherapeutics, Inc.
"Discovered via firm_website (high confidence)"
Developing novel CAR T cell therapies that transcend the limitations of current cell therapies.
Latus Bio
"Discovered via firm_website (high confidence)"
A patient-centric gene therapy company with a robust pipeline of product candidates in development for both rare and common CNS diseases.
Hula Therapeutics
"Discovered via firm_website (high confidence)"
A spinout from the Children's Hospital of Philadelphia focusing on identifying highly specific immunotherapy targets essential to tumors.
MasterSwitch Bio
"Discovered via firm_website (high confidence)"
Developed a modified mRNA therapy targeting Hepatocyte Nuclear Factor-4 alpha for the treatment of End Stage Liver Disease with cirrhosis.
Ladder Bio
"Discovered via firm_website (high confidence)"
Developed a novel chemical platform of synthetic, modular, fused-ring peptide-like structures for highly selective binding of proteins.
Browse More Investors
Frequently Asked Questions
See if Hatch BioFund is a match for your startup
Upload your pitch deck to see how well you match with Hatch BioFund and 200+ other VC firms.